EM2AI has received a Category 2 Medical Device Licence from the Food and Drug Administration (FDA) of Thailand; a Class B Medical Device Licence from the Food and Drug Administration (FDA) of the Philippines; a Class B Medical Device Licence from the Department of Medical Equipment and Construction (DMEC) of Vietnam; and a Class C Medical Device Licence from the Ministry of Health of Indonesia.
EM2AI, a 49% associated company of Mainboard-listed Q&M Dental, has received medical device licences from the relevant authorities in Thailand, Vietnam, Indonesia and the Philippines.
According to a Jan 13 bourse filing, EM2AI currently sells and distributes its artificial intelligence (AI) solutions in Singapore and Malaysia. Founded in 2018 and headquartered in Singapore, EM2AI has developed healthcare software for the dental industry, which it claims can serve as a “second opinion to increase diagnosis accuracy”.
